Part 5: BLS and CPR Quality: 2017 Guidelines Update Writing Group Disclosures
Writing Group Member Employment Research Grant Other Research Support Speakers’ Bureau/Honoraria Expert Witness Ownership Interest Consultant/Advisory Board Other
Monica E. Kleinman Children’s Hospital Boston None None None None None None None
Erin E. Brennan Kingston Resuscitation Institute (research grant in CPR education)* None None None None None None None
Bentley J. Bobrow Arizona Department of Health Services None None None None None None None
Raúl J. Gazmuri Rosalind Franklin University of Medicine and Science DePaul-Rosalind Franklin University Collaborative Pilot Research Grant Program (basic science research; study mechanisms by which cyclophilin-D modulates transcription of mitochondrial genes)†; James R. & Helen D. Russell Institute for Research & Innovation: Small Research Grants Program (basic science research; prevention of oxidative injury to the neonatal heart)*; Department of Defense US Army Medical Research and Material Command (translational research: sustained V1A receptor activation for prolonged hemodynamic support and neurological protection after noncompressible hemorrhage and traumatic brain injury)†; Zoll Medical Corp (translational research: AMSA to guide shock delivery in a swine model of ventricular fibrillation and closed chest resuscitation)† None None None None None None
Zachary D. Goldberger University of Washington None None None None None None None
Mary Fran Hazinski Vanderbilt University None None None None None American Heart Association ECC† None
Robin Hemphill Veterans Health Administration None None None None None None None
Thomas Rea University of Washington TBD TBD TBD TBD TBD TBD TBD
Robert A. Swor William Beaumont Hospital None None None None None None None
Mark Terry Johnson County MED-ACT None None None None None None None
Andrew H. Travers Emergency Health Services, Nova Scotia (Canada) TBD TBD TBD TBD TBD TBD TBD
This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $10 000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.

*Modest.

†Significant.